Percheron Therapeutics Ltd (ASX: PER) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Percheron Therapeutics Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Percheron Therapeutics Ltd (ASX: PER)
Latest News
Healthcare Shares
Here's why the Antisense (ASX:ANP) share price is climbing 5% today
Healthcare Shares
Antisense (ASX:ANP) share price accelerates 5% on FDA news
Capital Raising
Antisense Therapeutics (ASX:ANP) share price tumbles 8% amid capital raise
Share Fallers
Here's why the Antisense Therapeutics (ASX:ANP) share price has plummeted 19% on Monday
Healthcare Shares
Why the Antisense (ASX:ANP) share price rocketed 16% today
Share Market News
Why the Antisense (ASX:ANP) share price finished 5% higher today
Healthcare Shares
The Antisense (ASX:ANP) share price is surging 7% today. Here's why
Share Market News
Recent development sends the Antisense (ASX:ANP) share price soaring 45%
PER ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Percheron Therapeutics Ltd
Antisense Therapeutics Ltd. engages in the research and development of novel antisense pharmacceuticals. It operates through the ATL1102, and ATL1103 segments. The ATL1102 segment represents the second generation antisense inhibitor of CD49d, the alpha subunit of very late antigen-four. The ATL1103 segment refers to atesidorsen is an antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin. The company was founded on November 13, 2000 and is headquartered in Toorak, Australia.
